Pieris' Artificial Protein Platform Is Undervalued By The Street, Analyst Says
January 17, 2018 at 15:03 PM EST
Shares of the clinical-stage biotech companyPieris Pharmaceuticals Inc (NASDAQ: PIRS) are poised to outperform over the coming 12 ...